Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 8/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.42 |
| ▸ | HTR2A | P28223 | 2/20 | 0.42 |
| ▸ | HTR2B | P41595 | 2/20 | 0.42 |
| ▸ | ADRA1D | P25100 | 9/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 9/20 | 0.41 |
| ▸ | ADRA1B | P35368 | 9/20 | 0.41 |
| ▸ | DRD4 | P21917 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8584313 | 0.89 | DRD2 (0.41) | DRD2SLC6A4HTR2AHTR2BADRA1D | |
| SCHEMBL5957129 | 0.87 | ADRA1D (0.41) | DRD2SLC6A4HTR2AHTR2BADRA1D | |
| SCHEMBL5957058 | 0.85 | ALDH1A1 (0.45) | DRD2SLC6A4HTR2AHTR2BADRA1D | |
| SCHEMBL5957148 | 0.81 | DRD2 (0.43) | DRD2SLC6A4HTR2AHTR2BADRA1D | |
| SCHEMBL5957134 | 0.79 | DRD2 (0.47) | DRD2SLC6A4HTR2AHTR2BADRA1D | |
| SCHEMBL5957098 | 0.78 | DRD2 (0.48) | DRD2SLC6A4HTR2AHTR2BADRA1D | |
| SCHEMBL5957113 | 0.76 | ALDH1A1 (0.59) | DRD2SLC6A4HTR2AHTR2BDRD4 | |
| SCHEMBL5957074 | 0.73 | DRD2 (0.45) | DRD2SLC6A4HTR2AHTR2BADRA1D | |
| Aplindore SCHEMBL3192098 | 0.72 | DRD2 (0.68) | DRD2SLC6A4HTR2AHTR2BDRD4 | |
| Aplindore SCHEMBL119499 | 0.72 | DRD2 (0.68) | DRD2SLC6A4HTR2AHTR2BDRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1726592-A1 | Dioxino derivatives and their use as dopanine agonists | Wyeth a Corporation of the State of Delaware (US) | 2006-11-29 | — | — | EP | claimed |
| EP-1375503-A1 | Dioxino derivatives and their use as dopanine agonists | Wyeth (US) | 2004-01-02 | — | — | EP | claimed |
| EP-0771800-A2 | Dioxino derivatives and their use as dopamine agonists | AMERICAN HOME PRODUCTS CORPORATION (US) | 1997-05-07 | — | — | EP | claimed |
| EP-1726592-A1 | Dioxino derivatives and their use as dopanine agonists | Wyeth a Corporation of the State of Delaware (US) | 2006-11-29 | — | — | EP | disclosed |
| EP-1375503-A1 | Dioxino derivatives and their use as dopanine agonists | Wyeth (US) | 2004-01-02 | — | — | EP | disclosed |
| EP-0771800-A2 | Dioxino derivatives and their use as dopamine agonists | AMERICAN HOME PRODUCTS CORPORATION (US) | 1997-05-07 | — | — | EP | disclosed |